00:59:48 EDT Fri 10 May 2024
Enter Symbol
or Name
USA
CA



Auxly Cannabis Group Inc
Symbol XLY
Shares Issued 1,009,008,498
Close 2023-06-29 C$ 0.015
Market Cap C$ 15,135,127
Recent Sedar Documents

Auxly Cannabis shareholders approve AGM resolutions

2023-06-29 17:11 ET - News Release

Mr. Hugo Alves reports

AUXLY ANNOUNCES RESULTS OF ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS

Auxly Cannabis Group Inc. has released the voting results from its annual general and special meeting of shareholders held on June 29, 2023.

A total of 66,201,529 common shares of the company, representing 6.56 per cent of the issued and outstanding common shares of the company, were voted in connection with the meeting by shareholders and proxy holders.

The voting results for the matters put forward before the company's shareholders for consideration and approval, as set out in the company's information circular dated May 19, 2023, are set out in the attached table.

Each of the directors listed as a nominee in the circular was elected as a director of the company at the meeting. The detailed results of the vote for the election of directors held at the meeting are set out in the attached table.

At the meeting, Auxly shareholders approved the reappointment of Ernst & Young LLP (EY) as the company's auditor for the 2023 fiscal year and authorized the board of directors to fix its remuneration.

The share consolidation resolution (as defined in the circular) was not approved by the requisite two-thirds (66-2/3rds per cent) of the votes cast at the meeting.

A report of voting results on all resolutions voted on at the meeting will be available on SEDAR.

About Auxly Cannabis Group Inc.

Auxly is a leading Canadian consumer packaged goods company in the cannabis products market, headquartered in Toronto, Canada. The company's focus is on developing, manufacturing and distributing branded cannabis products that delight its consumers.

Auxly's vision is to be a leader in branded cannabis products that deliver on the company's consumer promise of quality, safety and efficacy.

© 2024 Canjex Publishing Ltd. All rights reserved.